Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junine Toy

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Open Forum Infectious Diseases|May 25, 2026
Successful Scale-up of Syphilis Testing Linked to Routine HIV Viral Load Monitoring in British ColumbiaKyle A Thompson, Matthew Clifford-Rashotte, Wendy Zhang, et al.
AIDS (London, England)|February 10, 2018
Adverse drug reactions to integrase strand transfer inhibitorsKatherine J Lepik, Benita Yip, Ana C Ulloa, et al.
The Lancet. HIV|June 7, 2024
Longitudinal evolution of the HIV effective reproduction number following sequential expansion of treatment as prevention and pre-exposure prophylaxis in British Columbia, Canada: a population-level programme evaluationViviane D Lima, Jielin Zhu, Rolando Barrios, et al.
Plos One|March 15, 2023
Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, CanadaLalani L Munasinghe, Junine Toy, Katherine J Lepik, et al.
BMC Public Health|March 26, 2026
Enhancing identification of suspected unregulated drug toxicity deaths in administrative health records: a case study among people with HIV in British Columbia, CanadaLy Nguyen, Paul Sereda, Michelle Lu, et al.
AIDS (London, England)|March 14, 2022
Evolving patterns of antiretroviral drug interactions in people with HIV in British Columbia, CanadaKatherine J Lepik, Lu Wang, Marianne Harris, et al.
Lancet Regional Health. Americas|September 28, 2022
Impact of SARS-CoV-2 lockdown on expansion of HIV transmission clusters among key populations: A retrospective phylogenetic analysisRachel L Miller, Angela McLaughlin, Vincent Montoya, et al.
AIDS Care|July 17, 2010
HIV antiviral drug resistance: patient comprehensionC Sarai Racey, Wendy Zhang, Eirikka K Brandson, et al.
Antiviral Therapy|February 20, 2024
Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, CanadaKatherine J Lepik, Olivia L Hunt, Nic Bacani, et al.
Open Forum Infectious Diseases|November 22, 2021
Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, CanadaKyle A Thompson, Gabriel Blank, Junine Toy, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Open Forum Infectious Diseases|May 25, 2026
Successful Scale-up of Syphilis Testing Linked to Routine HIV Viral Load Monitoring in British ColumbiaKyle A Thompson, Matthew Clifford-Rashotte, Wendy Zhang, et al.
AIDS (London, England)|February 10, 2018
Adverse drug reactions to integrase strand transfer inhibitorsKatherine J Lepik, Benita Yip, Ana C Ulloa, et al.
The Lancet. HIV|June 7, 2024
Longitudinal evolution of the HIV effective reproduction number following sequential expansion of treatment as prevention and pre-exposure prophylaxis in British Columbia, Canada: a population-level programme evaluationViviane D Lima, Jielin Zhu, Rolando Barrios, et al.
Plos One|March 15, 2023
Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, CanadaLalani L Munasinghe, Junine Toy, Katherine J Lepik, et al.
BMC Public Health|March 26, 2026
Enhancing identification of suspected unregulated drug toxicity deaths in administrative health records: a case study among people with HIV in British Columbia, CanadaLy Nguyen, Paul Sereda, Michelle Lu, et al.
AIDS (London, England)|March 14, 2022
Evolving patterns of antiretroviral drug interactions in people with HIV in British Columbia, CanadaKatherine J Lepik, Lu Wang, Marianne Harris, et al.
Lancet Regional Health. Americas|September 28, 2022
Impact of SARS-CoV-2 lockdown on expansion of HIV transmission clusters among key populations: A retrospective phylogenetic analysisRachel L Miller, Angela McLaughlin, Vincent Montoya, et al.
AIDS Care|July 17, 2010
HIV antiviral drug resistance: patient comprehensionC Sarai Racey, Wendy Zhang, Eirikka K Brandson, et al.
Antiviral Therapy|February 20, 2024
Adverse drug reactions attributed to generic substitution of antiretroviral medications among HIV treatment and pre-exposure prophylaxis clients in British Columbia, CanadaKatherine J Lepik, Olivia L Hunt, Nic Bacani, et al.
Open Forum Infectious Diseases|November 22, 2021
Chronic Hepatitis B Infection Among Preexposure Prophylaxis Users Enrolled in a Population-Based Program in British Columbia, CanadaKyle A Thompson, Gabriel Blank, Junine Toy, et al.
Pageof 3